Haploidentical versus matched donor stem cell transplantation for patients with hematological malignancies: a systemic review and meta-analysis
B Yang, R Yu, L Cai, B Guo, H Chen, H Zhang… - Bone marrow …, 2019 - nature.com
We compared the safety and efficacy of haploidentical stem cell transplantation (haplo-SCT)
to matched donor SCT (matched-SCT) in treating hematological malignancies. The Medline …
to matched donor SCT (matched-SCT) in treating hematological malignancies. The Medline …
Haploidentical‐versus identical‐sibling transplant for high‐risk pediatric AML: A multi‐center study
FM Zheng, X Zhang, CF Li, YF Cheng… - Cancer …, 2020 - Wiley Online Library
Background Human leukocyte antigen‐identical sibling donor (ISD)‐hematopoietic stem cell
transplantation (SCT) is a potentially curative treatment for high‐risk pediatric acute myeloid …
transplantation (SCT) is a potentially curative treatment for high‐risk pediatric acute myeloid …
Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual …
In patients with acute myeloid leukemia (AML) of intermediate-risk (IR) in first remission
(CR1) with no measurable residual disease (MRD negative), the choice of the best …
(CR1) with no measurable residual disease (MRD negative), the choice of the best …
Comparison of outcomes after donor lymphocyte infusion with or without prior chemotherapy for minimal residual disease in acute leukemia/myelodysplastic …
XD Mo, XH Zhang, LP Xu, Y Wang, CH Yan… - Annals of …, 2017 - Springer
The efficacy of donor lymphocyte infusion (DLI) without chemotherapy was investigated and
compared with that of chemotherapy prior to DLI (Chemo-DLI) in patients who were minimal …
compared with that of chemotherapy prior to DLI (Chemo-DLI) in patients who were minimal …
Review on haploidentical hematopoietic cell transplantation in patients with hematologic malignancies
WA Fabricius, M Ramanathan - Advances in hematology, 2016 - Wiley Online Library
Allogenic hematopoietic cell transplantation (HSCT) is typically the preferred curative
therapy for adult patients with acute myeloid leukemia, but its use has been reduced as a …
therapy for adult patients with acute myeloid leukemia, but its use has been reduced as a …
Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell …
MZ Shen, XX Liu, ZY Qiu, LP Xu… - Therapeutic …, 2022 - journals.sagepub.com
Purpose: Graft-versus-host disease (GVHD) is an important complication after human
leukocyte antigen (HLA) haploidentical donor (HID) hematopoietic stem cell transplantation …
leukocyte antigen (HLA) haploidentical donor (HID) hematopoietic stem cell transplantation …
The role of collateral related donors in haploidentical hematopoietic stem cell transplantation
XD Mo, YY Zhang, XH Zhang, LP Xu, Y Wang, CH Yan… - Science bulletin, 2018 - Elsevier
A key issue in the haploiedntical hematopoietic stem cell transplantation (haplo-HSCT)
setting is the search for the best donor, because donor selection can significantly impact the …
setting is the search for the best donor, because donor selection can significantly impact the …
Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical …
Y Wang, YJ Chang, L Chen, LP Xu, ZL Bian… - …, 2017 - Taylor & Francis
Use of high-dose, post-transplant cyclophosphamide (PTCy) results in low rates of graft-
versus-host-disease (GVHD) and favorable immune reconstitution, although with higher …
versus-host-disease (GVHD) and favorable immune reconstitution, although with higher …
[HTML][HTML] Machine learning algorithm as a prognostic tool for venous thromboembolism in allogeneic transplant patients
RX Deng, XL Zhu, AB Zhang, Y He, HX Fu… - … and Cellular Therapy, 2023 - Elsevier
As a serious complication after allogenic hematopoietic stem cell transplantation (allo-
HSCT), venous thromboembolism (VTE) is significantly related to increased nonrelapse …
HSCT), venous thromboembolism (VTE) is significantly related to increased nonrelapse …
[HTML][HTML] Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first …
“Beijing group” has pioneered a different approach with T-cell replete HID, intensive
myeloablation, a combination of G-CSF-primed bone marrow plus peripheral blood as the …
myeloablation, a combination of G-CSF-primed bone marrow plus peripheral blood as the …